SIS INT'L(00529.HK)上半年純利飆升94%至5181.9萬港元
格隆匯8月25日丨SIS INT'L(00529.HK)公佈截至2023年6月30日止六個月的中期業績,與去年同期相比,純利飆升94%至5181.9萬港元,惟收益則下跌至 43.72億港元。該跌幅反映出當前市場環境帶來的挑戰。純利的可觀增長,可歸因於集團的投資組合市值回升,而組合以美國上市證券為主。
於回顧期間,在地緣政治緊張的情況下,集團的業務營運遭受更嚴重影響,尤以香港為甚。利率上調、通脹高居不下、經濟增長放緩,加上生活成本不斷上升,均使營商情況日趨艱鉅。然而,在 COVID-19 疫情後,差旅逐步恢復,儘管復甦步伐依然緩慢,但仍透出一絲曙光,帶來動力與鼓勵。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.